Photo: Rubenstein, CC BY 2.0, via Wikimedia Commons

Maria C. Freire

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
11 years
Director since
2023

11 years of board service in total across 3 boards, counting each seat separately. Longest: Alexandria Real Estate Equities Inc., 3 years.

3 years · Since 2023
Exelixis Inc. Director
3 years · Since 2023
Biogen Inc. Director
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 9, 2026 Biogen Inc. Grant or award +2,005 — —
May 27, 2026 Exelixis Inc. Grant or award +8,367 — —
May 7, 2026 Exelixis Inc. Option exercise +20,634 $19.77 $407,934
May 7, 2026 Exelixis Inc. Open-market sale −20,634 $46.00 $949,164
Jan 15, 2026 Alexandria Real Estate Equities Inc. Grant or award +3,493 — —
Jun 17, 2025 Biogen Inc. Grant or award +2,370 — —
May 29, 2025 Exelixis Inc. Grant or award +9,812 — —
Feb 14, 2025 Exelixis Inc. Option exercise +15,874 $20.50 $325,417
Feb 14, 2025 Exelixis Inc. Option exercise +28,240 $22.10 $624,104
Feb 14, 2025 Exelixis Inc. Open-market sale −44,114 $34.94 $1,541,343
Jan 15, 2025 Alexandria Real Estate Equities Inc. Grant or award +2,032 — —
Aug 14, 2024 Exelixis Inc. Open-market sale −8,250 $26.56 $219,120
Jun 21, 2024 Biogen Inc. Grant or award +1,340 — —
May 31, 2024 Exelixis Inc. Grant or award +18,838 — —
Jan 12, 2024 Alexandria Real Estate Equities Inc. Grant or award +1,585 — —

Questions about Maria C. Freire

What boards is Maria C. Freire on?

Maria C. Freire sits on the boards of Alexandria Real Estate Equities Inc., Biogen Inc. and Exelixis Inc.

How long has Maria C. Freire served on boards?

Our records show at least 11 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.